|
|
|
Insider
Information: |
Secora Michael |
Relationship: |
Chief Financial Officer |
City: |
Salt Lake City |
State: |
UT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
1,402,131 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$10,053,279 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,402,131 |
|
|
Total
Value |
$10,053,279 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Recursion Pharmaceuticals, Inc. |
RXRX |
Chief Financial Officer |
2024-09-11 |
1,402,131 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RXRX |
Recursion Pharmaceuticals... |
Chief Financial OfficerOfficer |
|
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
379,685 |
|
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
149,077 |
528,762 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2021-04-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(528,762) |
0 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2021-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
528,762 |
528,762 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
60,299 |
590,449 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-02-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
60,299 |
591,058 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
210,163 |
798,237 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
182,849 |
1,163,863 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-05-16 |
4 |
D |
$5.67 |
$6,061 |
D/D |
(1,069) |
588,702 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-02-04 |
4/A |
D |
$11.40 |
$7,729 |
D/D |
(678) |
590,380 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-02-04 |
4 |
D |
$11.40 |
$7,729 |
D/D |
(678) |
589,771 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-02-15 |
4 |
D |
$8.44 |
$10,618 |
D/D |
(1,258) |
794,310 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-11-15 |
4 |
D |
$11.86 |
$12,631 |
D/D |
(1,065) |
586,572 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2022-08-15 |
4 |
D |
$12.96 |
$13,802 |
D/D |
(1,065) |
587,637 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-02-01 |
4 |
D |
$8.55 |
$22,820 |
D/D |
(2,669) |
795,568 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2024-02-09 |
4 |
D |
$10.09 |
$25,346 |
D/D |
(2,512) |
1,161,351 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-05-15 |
4 |
D |
$5.60 |
$26,656 |
D/D |
(4,760) |
790,159 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-08-15 |
4 |
D |
$9.19 |
$43,441 |
D/D |
(4,727) |
838,186 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-11-15 |
4 |
D |
$7.18 |
$51,495 |
D/D |
(7,172) |
931,014 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2024-08-15 |
4 |
D |
$6.69 |
$80,026 |
D/D |
(11,962) |
1,353,381 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-06-13 |
4 |
OE |
$2.22 |
$83,250 |
D/D |
37,500 |
830,413 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-06-14 |
4 |
OE |
$2.22 |
$83,250 |
D/D |
37,500 |
842,913 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-07-18 |
4 |
OE |
$2.22 |
$83,250 |
D/D |
37,500 |
855,413 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-07-19 |
4 |
OE |
$2.22 |
$83,250 |
D/D |
37,500 |
867,913 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
Chief Financial Officer |
|
2023-08-15 |
4 |
OE |
$2.22 |
$83,250 |
D/D |
37,500 |
875,686 |
0 |
- |
|
82 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|